Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymph Node-negative”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05935150
What this trial is testing

Omission of SLNB in CN0 Early Breast Cancer

Who this might be right for
Breast CancerClinically Assessed Negative Axillary Lymph NodesSentinel Lymph Node
The First Affiliated Hospital with Nanjing Medical University 311
Large-scale testing (Phase 3)UnknownNCT01662128
What this trial is testing

Efficacy and Safety Of Xeloda as Sequential Adjuvant Therapy After Chemotherapy in Breast Cancer

Who this might be right for
Breast Cancer
Tianjin Medical University 600
Not applicableStudy completedNCT02031042
What this trial is testing

Sentinel Node Biopsy Before and/or After Neoadjuvant Chemotherapy in Breast Cancer

Who this might be right for
Breast Cancer
Stockholm South General Hospital 224
Not applicableStudy completedNCT06439745
What this trial is testing

More Than 50% of Unifocal cN0 T1b/Small T2 Papillary Thyroid Carcinoma May Require Completion Thyroidectomy if Nodal Status is Evaluated

Who this might be right for
Papillary Thyroid CancerPapillary CarcinomaThyroid Cancer+3 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 314
Not applicableEnded earlyNCT03433937
What this trial is testing

Prevention of Seroma Following Inguinal Lymph Node Dissection With Prophylactic Incisional Negative Pressure Wound Therapy

Who this might be right for
SeromaSurgical Site InfectionLymphedema+1 more
Odense University Hospital 20
Large-scale testing (Phase 3)Not Yet RecruitingNCT07757958
What this trial is testing

Partial Breast Irradiation Without Sentinel Lymph Node Biopsy in Low-Risk Early Breast Cancer

Who this might be right for
Breast CancerNode-negative Breast CancerEarly-Stage Invasive Breast Carcinoma
Samsung Medical Center 520
Not applicableStudy completedNCT01351974
What this trial is testing

Sentinel Node Biopsy in Breast Cancer Patients

Who this might be right for
RecurrenceBreast Cancer
Uppsala University 3,369
Testing effectiveness (Phase 2)WithdrawnNCT06990737
What this trial is testing

Phase 2 Pragmatic Trial of Sentinel Lymph Node Biopsy (SLNB) in Patients With Clinically Node-Negative (cN0), High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) of the Head and Neck

Who this might be right for
Cutaneous Squamous Cell Carcinoma of the Head and NeckClinically Node-Negative (cN0)High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) of the Head and Neck
University of California, Davis
Large-scale testing (Phase 3)Study completedNCT00003830
What this trial is testing

Surgery to Remove Sentinel Lymph Nodes With or Without Removing Lymph Nodes in the Armpit in Treating Women With Breast Cancer

Who this might be right for
Breast Cancer
NSABP Foundation Inc 5,611
Testing effectiveness (Phase 2)Looking for participantsNCT05981001
What this trial is testing

Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer

Who this might be right for
Breast Neoplasms
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 170
Not applicableActive Not RecruitingNCT04101851
What this trial is testing

Omission of SLNB in Triple-negative and HER2-positive Breast Cancer Patients With rCR and pCR in the Breast After NAST

Who this might be right for
Breast Cancer FemaleBreast Cancer
Toralf Reimer, MD PhD 350
Not applicableStudy completedNCT03773575
What this trial is testing

Evaluation of Closed Incision Negative Pressure Dressing (PREVENA) to Prevent Lower Extremity Amputation Wound Complications

Who this might be right for
AmputationAmputation; Postoperative, SequelaeWound Dehiscence+3 more
Thomas Jefferson University 272
Not applicableLooking for participantsNCT04671511
What this trial is testing

Targeted Axillary Dissection (TAD) in Early-stage Node Positive Breast Cancer

Who this might be right for
Breast Cancer FemaleEarly-stage Breast CancerLymph Node Metastases+2 more
Jewish General Hospital 98
Large-scale testing (Phase 3)Active Not RecruitingNCT00798070
What this trial is testing

Panther: A Study Comparing Biweekly and Tailored EC-T Versus Three Weekly FEC-T in Breast Cancer Patients

Who this might be right for
Breast Cancer
Karolinska University Hospital 2,017
Not applicableLooking for participantsNCT07546695
What this trial is testing

Role of Axillary Lymph Node Dissection for Residual MACROMETASTASES After NEOADJUVANT Chemotherapy in Patients With HER2+ and Triple Negative Breast Cancer: The OPBC-11/MACRONAC Study

Who this might be right for
Breast Cancer
University Hospital, Basel, Switzerland 600
Not applicableStudy completedNCT00282035
What this trial is testing

RAPID: Randomized Trial of Accelerated Partial Breast Irradiation

Who this might be right for
Breast Cancer
Ontario Clinical Oncology Group (OCOG) 2,135
Testing effectiveness (Phase 2)Study completedNCT01642511
What this trial is testing

Internal Mammary Sentinel Lymph Node Biopsy in Early Breast Cancer Patients With Clinically Axillary Node -Negative

Who this might be right for
Breast Cancer
Shandong Cancer Hospital and Institute 407
Early research (Phase 1)Study completedNCT02227082
What this trial is testing

Olaparib and Radiotherapy in Inoperable Breast Cancer

Who this might be right for
Locally Advanced Malignant NeoplasmInflammatory Breast CarcinomaTriple-Negative Invasive Breast Carcinoma
The Netherlands Cancer Institute 7
Testing effectiveness (Phase 2)Ended earlyNCT04476797
What this trial is testing

Phase I/II Study of SBRT and GC4711 for Centrally Located or Large NSCLC

Who this might be right for
SBRTNSCLCNon-metastatic
Galera Therapeutics, Inc. 47
Not applicableNot Yet RecruitingNCT07533357
What this trial is testing

Tpex Subsets in Negative Tumor Draining Lymph Nodes for Predicting the Efficacy of PD 1 Inhibitors in Advanced or Recurrent Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Cancer
Fudan University 158
Next Page